businessbriefs
11:18in productionCh. 1 · Not a startup. A spin-off./ 11:18 · ceiling 15 min
Companies

Corteva

2018

Corteva is not a startup—it’s DowDuPont’s agriculture division, spun off to sell more chemicals while pretending to pivot away from them.

Corteva is a post-merger agricultural platform—neither innovative nor disruptive, but operationally disciplined. It monetises legacy chemistry while layering biologicals and biofuels as defensive growth vectors. Its real constraint is not R&D capacity, but regulatory tolerance for animal testing and neurotoxic pesticides.

Chapters & takeaways4
  1. 1:05
    Not a startup. A spin-off.

    Corteva is a corporate carve-out—not a founder-led venture—but a legally distinct entity built to monetise DowDuPont’s agricultural IP.

  2. 2:42
    Testing beagles while retiring chlorpyrifos

    It commissions animal testing while phasing out one neurotoxic pesticide—showing regulatory compliance and reputational management, not systemic reform.

  3. 4:54
    Biologicals by acquisition, not invention

    Its $1.2 billion acquisition of Stoller Group signals a real bet on biologicals—but only as an additive, not a replacement, to its chemical portfolio.

  4. 6:48
    Two strategies, one balance sheet

    Its 2025 fungicide launch and 2024 BP biofuel deal reveal parallel tracks: defending core chemistry markets while seeking low-carbon adjacency.

Worth your time?

Yes. Study the whole thing.

3.5/ 5
What works
  • business/companies
  • business/strategy
  • business/product
What does not
  • business/startups-and-venture
  • business/founders
  • business/ideas
Study it if
  • investors
  • regulators
  • agribusiness procurement teams
Skip it if
  • consumers
  • activists
  • students of innovation
The written brief1 min read

What the company or idea is

Corteva is a U.S.-based public company formed in March 2018 as DowDuPont’s agriculture subsidiary, focused exclusively on seeds and crop protection.

How it actually makes money

Corteva makes money selling seeds and crop protection products—including herbicides, insecticides, fungicides, and biologicals—in 110 countries.

What works

Its acquisition strategy works: the $1.2 billion purchase of Stoller Group and Symborg expanded its biologicals portfolio credibly, and its BP partnership signals credible downstream diversification beyond field crops.

What does not

Its public narrative of sustainability does not align with its commissioning of beagle testing in 2019 or its continued reliance on synthetic fungicides like flutriafol, even as it markets biological acquisitions.

What to take from it

Corteva is not a new entrant but a carved-out incumbent—structured to operate at scale, acquire selectively, and separate high-margin seed IP from lower-margin pesticide logistics, all while navigating tightening regulation and consumer scrutiny.

Is it worth your time

Yes—if you are tracking how legacy agribusinesses restructure, pivot into biologicals, and manage regulatory and reputational risk while maintaining chemical portfolios.

Same desk · Companies4 of 297
10:34
Airbus1998Airbus in 1998 was a consortium — not a company — sustained by national governments and bound by treaty, not equity. Its money came from airliner sales, but its structure reflected diplomacy more than business logic. It worked because Europe prioritised strategic autonomy over market efficiency. It failed as a unified enterprise until it abandoned the consortium model entirely. The lesson is structural: scale in aerospace is political first, economic second.
12:10
Anglo American plc1917Anglo American plc is a British multinational mining company headquartered in London, founded in 1917 in Johannesburg. It is the world's largest platinum producer (40% of global output) and owns 85% of De Beers. It merged with Minorco in 1999 to become Anglo American plc, and with Teck Resources in 2025 to form Anglo Teck. Between 2015 and 2015, it cut 138,000 jobs. In early 2015, it reported a $3 billion loss. It withdrew from the Pebble Mine in 2013 and partnered with Engie and First Mode in 2019 to develop a hydrogen-powered haul truck.
12:01
Birks GroupHenry Birks · 2005Birks Group is the legal successor to Henry Birks and Sons — a Canadian jeweller founded in 1879, vertically integrated from design to retail, with manufacturing roots in Roden Bros. and national reach built through owned stores and co-branded acquisitions. Its 2005 merger with Mayors was a structural consolidation, not a new beginning.
11:34
Chorus Limited2011Chorus is a state-shaped infrastructure monopoly built from a 2011 demerger. It controls the physical layer of New Zealand’s internet — but not the customer relationship, pricing, or service design. Its success is measured in coverage and uptake, not profit per user or innovation. It works because regulation forces openness — not because it competes.
Up next in Business

Disruptive innovation

1995 · 10:03

Disruption isn’t what breaks markets—it’s what incumbents ignore until it’s too late.

10:03